MYCN and neuroblastoma: Clinical and molecular risk factors that correlate with prognosis include age at diagnosis, stage, histology, chromosomal aberrations, and amplification of the N-Myc proto-oncogene (MYCN), which is the most typical genetic feature of advanced-stage NB [5,7,8].